Cited by 54Dementia and Cognitive Impairment ResearchTreatment of Major DepressionMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study

Open access

Abstract

BACKGROUND: Antidepressants are commonly prescribed medications in the elderly, but their relationship with incident mild cognitive impairment (MCI) and probable dementia is unknown. METHODS: The study cohort included 6,998 cognitively healthy, postmenopausal women, aged 65-79 years, who were enrolled in a hormone therapy clinical trial and had baseline depressive symptoms and antidepressant use history assessments at enrollment, and at least one postbaseline cognitive measurement. Participants were followed annually and the follow-up averaged 7.5 years for MCI and probable dementia outcomes. A central adjudication committee classified the presence of MCI and probable dementia based on extensive neuropsychiatric examination. RESULTS: Three hundred and eighty-three (5%) women were on antidepressants at baseline. Antidepressant use was associated with a 70% increased risk of MCI, after controlling for potential covariates including the degree of depressive symptom severity. Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) were both associated with MCI (SSRIs: hazard ratios (HR), 1.78 [95% CI, 1.01-3.13]; TCAs: HR, 1.78 [95% CI, 0.99-3.21]). Depressed users (HR, 2.44 [95% CI, 1.24-4.80]), non-depressed users (HR, 1.79 [95% CI, 1.13-2.85]), and depressed non-users (HR, 1.62 [95% CI, 1.13-2.32]) had increased risk of incident MCI. Similarly, all three groups had increased risk of either MCI or dementia, relative to the control cohort. CONCLUSIONS: Antidepressant use and different levels of depression severity were associated with subsequent cognitive impairment in a large cohort of postmenopausal women. Future research should examine the role of antidepressants in the depression-dementia relationship and determine if antidepressants can prevent incident MCI and dementia in individuals with late-life depression subtypes with different levels of severity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1041610211002778

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Peakman et al. (2020) and Goveas et al. (2012) found that antidepressant use was associated with dementia risk (adjusted HR 1.32 [95% CI 1.01-1.74] and 1.69 [95% CI 1.21-2.35], respectively), but no association was found for SSRIs (adjusted HR 1.07 [95% CI 0.91-1.25] and 1.50 [95% CI 0.89-2.53], respectively).

    “Nonetheless, Peakman et al., 2020 [33] and Goveas et al., 2012 [34] pointed out that even though antidepressant use was found to be associated with the risk of dementia (adjusted hazard ratio [HR]: 1.32 [95% CI: 1.01–1.74] and 1.69 [95% CI: 1.21–2.35], respectively), an association was not found for SSRIs (adjusted HR: 1.07 [95% CI: 0.91–1.25] and 1.50 [95% CI: 0.89–2.53], respectively).”

    From Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study (2023) · cites this paper as [34]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. Aboukhatwa, 2010, Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease, Molecular Neurodegenertion, 5, 10, 10.1186/1750-1326-5-10 · DOI
  2. Almeida, 2010, Depression, antidepressant use and mortality in later life: the health in men study, PLoS One, 5, e11266, 10.1371/journal.pone.0011266 · DOI
  3. Borhani, 1991, Systolic Hypertension in the Elderly Program (SHEP). Part 1: rationale and design, Hypertension, 17, II2, 10.1161/01.HYP.17.3_Suppl.II2 · DOI
  4. Butters, 2008, Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B, Alzheimer Disease and Associated Disorders, 22, 261, 10.1097/WAD.0b013e31816c92bf · DOI
  5. Culang, 2009, Change in cognitive functioning following acute antidepressant treatment in late-life depression, American Journal of Geriatric Psychiatry, 17, 881, 10.1097/JGP.0b013e3181b4bf4a · DOI · Paper page
  6. Goveas, 2011, Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study, Journal of the American Geriatric Society, 59, 57, 10.1111/j.1532-5415.2010.03233.x · DOI
  7. Haney, 2010, Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?, Bone, 46, 13, 10.1016/j.bone.2009.07.083 · DOI
  8. Hashioka, 2009, Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease, Central Nervous System Agents in Medicinal Chemistry, 9, 12, 10.2174/187152409787601897 · DOI
  9. Irie, 2008, Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study, Archives of General Psychiatry, 65, 906, 10.1001/archpsyc.65.8.906 · DOI
  10. Knegtering, 1994, Effects of antidepressants on cognitive functioning of elderly patients. A review, Drugs and Aging, 5, 192, 10.2165/00002512-199405030-00005 · DOI
  11. Lee, 2007, Persistent mild cognitive impairment in geriatric depression, International Psychogeriatrics, 19, 125, 10.1017/S1041610206003607 · DOI
  12. Mark, 2011, Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costs, American Journal of Geriatric Psychiatry, 19, 211, 10.1097/JGP.0b013e3181f1803d · DOI
  13. Mossello, 2008, Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease, Dementia and Geriatric Cognitive Disorders, 25, 372, 10.1159/000121334 · DOI · Paper page
  14. Ownby, 2006, Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis, Archives of General Psychiatry, 63, 530, 10.1001/archpsyc.63.5.530 · DOI · Paper page
  15. Rajji, 2008, Use of antidepressants in late-life depression, Drugs and Aging, 25, 841, 10.2165/00002512-200825100-00003 · DOI
  16. Ravaglia, 2008, Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort, American Journal of Geriatric Psychiatry, 16, 834, 10.1097/JGP.0b013e318181f9b1 · DOI
  17. Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328 · DOI · Paper page
  18. Sapolsky, 2000, Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders, Archives of General Psychiatry, 57, 925, 10.1001/archpsyc.57.10.925 · DOI · Paper page
  19. Sheline, 2010, Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial, Archives of General Psychiatry, 67, 277, 10.1001/archgenpsychiatry.2009.204 · DOI · Paper page
  20. Shumaker, 1998, The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia, Controlled Clinical Trials, 19, 604, 10.1016/S0197-2456(98)00038-5 · DOI
  21. Shumaker, 2004, Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study, JAMA, 291, 2947, 10.1001/jama.291.24.2947 · DOI
  22. Smoller, 2009, Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study, Archives of Internal Medicine, 169, 2128, 10.1001/archinternmed.2009.436 · DOI
  23. Steffens, 2000, Hippocampal volume in geriatric depression, Biological Psychiatry, 48, 301, 10.1016/S0006-3223(00)00829-5 · DOI
  24. Steffens, 2004, Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study, Journal of Geriatric Psychiatry and Neurology, 17, 202, 10.1177/0891988704269819 · DOI · Paper page
  25. Steffens, 2008, Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study, Stroke, 39, 857, 10.1161/STROKEAHA.107.498097 · DOI
  26. Tuunainen, 2001, Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview, Psychiatry Research, 103, 261, 10.1016/S0165-1781(01)00278-5 · DOI
  27. Weintraub, 2010, Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes, American Journal of Geriatric Psychiatry, 18, 332, 10.1097/JGP.0b013e3181cc0333 · DOI
  28. Wright, 2009, Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study, Journal of the American Geriatric Society, 57, 243, 10.1111/j.1532-5415.2008.02127.x · DOI

Cited by

Sorted by citations

Metadata

Authors
Goveas, J. S., Hogan, P. E., Kotchen, J. M., Smoller, J. W., Denburg, N. L., Manson, J. E., Tummala, A., Mysiw, W. J., Ockene, J. K., Woods, N. F., Espeland, M. A., & Wassertheil-Smoller, S.
Affiliations
  • Medical College of Wisconsin (US)
  • Wake Forest University Health Sciences (US)
  • Massachusetts General Hospital (US)
  • University of Iowa (US)
  • Brigham and Women's Hospital (US)
  • The Ohio State University Wexner Medical Center (US)
  • University of Massachusetts Chan Medical School (US)
  • University of Washington (US)
  • Albert Einstein College of Medicine (US)
Corresponding author
Goveas, Joseph S.
Venue
International Psychogeriatrics
Publisher
Elsevier BV
Published
2012-08
Volume
24
Issue
8
Pages
1252-1264
ISSN
1041-6102 (ISSN-L)
OpenAlex
W2039400277
Cited by
54
References
7
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 2
FWCI
2.19
Type
journal article
Language
en
Open access
Locations
  • International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship@UMassChan (submittedVersion)
Funders
  • U.S. Department of Health and Human Services
  • National Institutes of Health (n01wh32105-27-0-1, n01wh32108-30-0-1, n01wh32112-26-0-1, n01wh32100-28-0-1, n01wh32118-27-0-1, n01wh32111-28-0-1, n01wh32115-26-0-1, n01wh22110-38-0-0, N01-WH-3-2115, N01WH24152, N01 WH024152, n01wh24152-12-0-0, n01wh32122-31-0-1, n01wh32119-24-0-1, N01-WH-3-2122, N01-WH-32108-9, N01WH 32111-13, N01 WH 32105-6, N01 WH032108, N01 WH022110, N01 WH032105, N01-WH-32100-2, N01 WH032118, N01 WH032115, N01 WH032119, N01WH 32118-32119, N01 WH032111, N01 WH032112)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
antidepressant use, depressive symptoms, mild cognitive impairment, dementia, postmenopausal women, selective serotonin reuptake inhibitors, tricyclic antidepressants, geriatric depression, cognitive aging, Women's Health Initiative Memory Study
MeSH terms
Aged, Antidepressive Agents, Climacteric, Cross-Sectional Studies, Dementia, Depressive Disorder, Female, Follow-Up Studies, Health Surveys, Humans, Prospective Studies, Risk Factors, United States, Cohort Studies, Comorbidity, Estrogen Replacement Therapy, Incidence, Proportional Hazards Models, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review